Copyright
©The Author(s) 2020.
World J Psychiatr. Apr 19, 2020; 10(4): 46-58
Published online Apr 19, 2020. doi: 10.5498/wjp.v10.i4.46
Published online Apr 19, 2020. doi: 10.5498/wjp.v10.i4.46
Total group (n = 180) | Delirium (n = 44) | Comorbid delirium-dementia (n = 60) | Dementia (n = 30) | No neurocognitive disorder (n = 46) | |
Female (%) | 51% | 53% | 56% | 37% | 48% |
Age | 79.6 ± 7.2 | 77.7 ± 8.4 | 80.1 ± 7.0 | 81.8 ± 4.6 | 79.3 ± 7.5 |
Total number of medications | 10.1 ± 4.7 | 10.0 ± 4.2 | 10.3 ± 5.0 | 9.7 ± 4.4 | 10.3 ± 5.1 |
Number of psychotropics2 | 1.7 ± 1.6 | 1.9 ± 1.6 | 2.2 ± 1.7 | 1.7 ± 1.6 | 0.8 ± 1.1 |
DRS-R98 total12 | 17.0 ± 9.2 | 22.9 ± 5.7 | 24.0 ± 6.0 | 10.9 ± 4.4 | 6.5 ± 3.3 |
Short IQCODE3 | 3.7 ± 0.7 | 3.1 ± 0.1 | 4.4 ± 0.5 | 4.0 ± 0.5 | 3.1 ± 0.1 |
- Citation: Meagher DJ, O’Connell H, Leonard M, Williams O, Awan F, Exton C, Tenorio M, O’Connor M, Dunne CP, Cullen W, McFarland J, Adamis D. Comparison of novel tools with traditional cognitive tests in detecting delirium in elderly medical patients. World J Psychiatr 2020; 10(4): 46-58
- URL: https://www.wjgnet.com/2220-3206/full/v10/i4/46.htm
- DOI: https://dx.doi.org/10.5498/wjp.v10.i4.46